首页   按字顺浏览 期刊浏览 卷期浏览 Autopsy‐proven causes of death in HIV‐infected patients treated for tuber...
Autopsy‐proven causes of death in HIV‐infected patients treated for tuberculosis in Abidjan, Côte d'lvoire

 

作者: Alan Greenberg,   Sebastian Lucas,   Odette Tossou,   Issa-Malik Coulibaly,   Doulhourou Coulibaly,   Sidibé Kassim,   Alain Ackah,   Kevin De Cock,  

 

期刊: AIDS  (OVID Available online 1995)
卷期: Volume 9, issue 11  

页码: 1251-1254

 

ISSN:0269-9370

 

年代: 1995

 

出版商: OVID

 

关键词: Autopsy;tuberculosis;HIV;Africa

 

数据来源: OVID

 

摘要:

ObjectiveTo determine autopsy-proven causes of death in HIV-infected patients treated for tuberculosis in Abidjan, Côte d'lvoire.MethodsA computerized listing of 9523 patients diagnosed with tuberculosis, and tested for HIV infection at Abidjan's two large tuberculosis treatment centers from July 1989 to December 1991 was matched against a listing of 496 patients who were autopsied in Abidjan's largest public hospital in 1991–1992.ResultsFifteen matching patients were identified including 11 adults with smear-positive pulmonary tuberculosis, three adults with extrapulmonary tuberculosis, and one child with smear-negative pulmonary tuberculosis. The autopsy-proven causes of death among the adults were tuberculosis (n = 4), bacterial infections (n = 3), cerebral toxoplasmosis (n = 2), pulmonary nocardiosis (n = 2),Pneumocystis cariniipneumonia (n = 1), atypical mycobacteriosis (n = 1), and wasting syndrome (n = 1). Tuberculosis was the primary cause of death in two of five smear-positive patients who had not completed therapy, in none of the six patients with smear-positive disease who had completed therapy, and in two of the three patients with extrapulmonary tuberculosis.ConclusionsChemoprophylaxis with trimethoprim-sulfamethoxazole (TMP-SMX) might have provided benefit to eight (57%) of the 14 adults in this series who died either of bacterial infections, toxoplasmosis, nocardiosis, or pneumocystosis. Prospective studies are required to elucidate further the causes of increased mortality, and to evaluate the benefits of TMP-SMX prophylaxis in HIV-infected African patients with tuberculosis.

 

点击下载:  PDF (462KB)



返 回